Director, Clinical Research
Hello Heart · Remote · US only
$180k–$197k/yrFull-time

Avalyn PharmaRemote · US onlyPosted 1 month ago
$220k–$242k/yr listed by the employer
On Avalyn Pharma’s own careers site (Greenhouse).
Summarised from the posting by AI and can be wrong. The full description is the source.
Sign in and add your resume to see which of this job's requirements it shows.
Sign in to check your matchSaved to your account, encrypted. The AI that reads it doesn't keep it or train on it.
From Avalyn Pharma’s careers site
About Avalyn:
Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn’s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn’s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its proprietary drug-device approach and deep expertise in rare respiratory disease development, Avalyn aims to establish a new standard of care in pulmonary fibrosis through inhaled, lung-targeted therapies. For more information, please visit avalynpharma.com and follow the company on LinkedIn.
Position Summary:
The Director, Clinical Development Research Scientist will report to the Senior Vice President, Clinical Development and serve as a key clinical and scientific leader advancing Avalyn’s IPF/ILD clinical development programs. This individual will provide therapeutic-area expertise and strategic leadership across the development lifecycle, from program and study strategy through protocol design, clinical execution, data interpretation, regulatory interactions, and development planning.
The Director will lead one or more clinical trials and partner closely with Clinical Operations, Biostatistics, Regulatory Affairs, Pharmacovigilance, Translational Science, Data Management, CMC, and other functions to ensure clinical trial activities are scientifically rigorous, patient-focused, operationally feasible, and aligned with broader program objectives.
This individual will help shape development strategy, including study design, endpoints, development sequencing, risk assessment, data interpretation, and program-level decision-making. The Director will also provide medical and scientific expertise across multiple studies, serve as a resource to investigators and external experts, and contribute to regulatory interactions, advisory boards, publications, and scientific presentations.
The successful candidate will bring a balance of strategic thinking and hands-on clinical development expertise, with the ability to translate emerging clinical data into actionable development decisions.
Responsibilities:
Clinical Development Strategy & Program Leadership
Study Design & Clinical Trial Leadership
Medical Oversight, Safety & Data Interpretation
Clinical Documentation & Regulatory
Cross-Functional & External Leadership
Scientific Communications
Qualifications:
Proposed pay range
$220,000—$242,000 USD
Something wrong with this job? Report it
Hello Heart · Remote · US only
$180k–$197k/yrFull-time
StrongChecked open todayPosted 10 days ago

Generate Biomedicines · Remote · US only
$186k–$279k/yr
StrongChecked open todayPosted 14 days ago

Deciphera Pharmaceuticals · Remote · US only
$193k–$230k/yrFull-time
StrongChecked open todayPosted 18 days ago

Natera · Remote · US only
$172k–$215k/yr
StrongChecked open todayPosted 18 days ago

Recursion · Remote · US, UK +1 place
$288k–$346k/yr
StrongChecked open todayPosted 2 days ago

Amylyx Pharmaceuticals · Remote · US only
$221k–$249k/yr
StrongChecked open todayPosted 17 days ago